Solugen: Company Profile & Valuation

Solugen is a US biomanufacturing company that believes planet-scale change starts at the molecular level, harnessing the power of biology and chemistry to reimagine how life's essential materials are manufactured with the world's first sustainable chemical plant. Its Bioforge platform converts feedstock into a near-final chemical product using engineered enzymes and metal catalysts, with higher selectivity, higher conversion, and lower temperatures than traditional processes, at a yield of one ton of product per ton of feedstock.

Founded in 2017 when Gaurab and Sean built a prototype reactor from Home Depot materials for the MIT Entrepreneurship Competition, Solugen now partners with companies such as ADM, Sasol Chemicals and Kurita America on sustainable and carbon-negative chemical products.

Listed funds carry late-stage private names. A fund's latest schedule of investments shows whether it holds Solugen.

Often trade at a premium or discount to NAV.

Platforms match existing holders with buyers. Solugen availability at any moment is set by the holders.

High minimums, transfer approval, company right-of-first-refusal.

Valuations, rounds and IPO status for every company in the directory — Solugen included.

The routes section explains what is realistically available for a company at this stage.

No. Solugen is a private company; its shares do not trade on a public exchange.

The last valuation is $2B (post-money, Mar 2026).

Lead investors for each round are in the funding timeline.